Novel Coronavirus (SARS-CoV-2/COVID-19)

The National Academies of Science, Engineering and Medicine released A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus to assist and guide the federal government and decision-making bodies, including the Advisory Committee on Immunization Practices, as well as state, tribal…
Department of Health and Human Services Secretary Alex Azar announced the renewal of the COVID-19 national public health emergency declaration.
While hospitals and health systems — and their brave front-line caregivers — continue to battle the greatest public health challenge of our lifetimes, the Department of Health and Human Services recently made a change to its COVID-19 Provider Relief Fund (PRF) reporting requirements that could…
The Department of Health and Human Services Assistant Secretary for Preparedness and Response has released a recording of its Sept. 24 webinar on strategies to optimize personal protective equipment and supplies during the COVID-19 public health emergency.
A vast majority of nurse leaders (86%) feel prepared for a future COVID-19 surge, according to more than 1,800 nurse leaders the AHA’s American Organization for Nursing Leadership surveyed in July about pandemic preparedness and other key issues.
The Food and Drug Administration posted updated comparative performance data for molecular tests to diagnose the COVID-19 virus.
Beginning October 1, American hospitals can purchase Veklury (remdesivir) directly from the drug’s distributor, the Department of Health and Human Services announced today.
The Department of Health and Human Services today announced the availability of $20 billion to hospital and providers through the third Provider Relief Fund general distribution. The application period begins Oct. 5.
The Department of Health and Human Services (HHS) today announced the forthcoming distribution to all hospitals, as well as other providers, of $20 billion in funds from the Public Health and Social Services Emergency Fund